"Vilniaus „Kardiolitos klinikose“ konsultuoja ir gydo daugiau kaip 260 aukščiausios kvalifikacijos gydytojų specialistų, atstovaujančių daugiau kaip 45-ioms medicinos sritims. Modernia medicinos įranga operatyviai atliekami išsamūs instrumentiniai ir laboratoriniai tyrimai. Atliekamas profilaktinis sveikatos patikrinimas, vykdoma nėščiųjų priežiūra. Teikiamos chirurginio gydymo paslaugos: atliekamos dienos chirurgijos (taip pat ir minimaliai invazinės) bei sudėtingiausios (trečio lygio) širdies, ortopedinės ir kt. operacijos. Teikiamos terapinio gydymo paslaugos: įvairių ligų planinė diagnostika ir planinis gydymas."

During the past decade, Jsc Kardiolita conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jsc Kardiolita" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jsc Kardiolita" are "Menopausal Symptoms" (1 trials), "Traumatic Articular Cartilage Defects in the Knee Joint" (1 trials), "Uterine Fibroids" (1 trials) and "Vasomotor Symptoms" (1 trials). Many other conditions were trialed in "Jsc Kardiolita" in a lesser frequency.

Most popular intervention types in "Jsc Kardiolita" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Estetrol oral tablet" (1 trials), "Microfracture" (1 trials), "NOVOCART® 3D plus" (1 trials), "Placebo oral tablet" (1 trials) and "Progesterone oral tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jsc Kardiolita" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Jsc Kardiolita". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jsc Kardiolita, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jsc Kardiolita, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".